Adar1-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "JWN",
  "MRUS",
  "AKRO",
  "KNSA",
  "ASND",
  "EWTX",
  "CNTA",
  "NKTR",
  "INSM",
  "RVMD",
  "TIL",
  "ARGX",
  "AQN",
  "EXAS",
  "MDGL",
  "APLS",
  "ARWR",
  "PTCT",
  null,
  null,
  null,
  "IROH",
  null,
  null,
  null,
  null,
  null,
  null,
  "ABVX",
  null,
  "DVAX",
  "MREO",
  "RGNX",
  "RXRX",
  "SWTX",
  "RCKT",
  "ARVN",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TSHA",
  "ACHV",
  "NRIX",
  "STOK",
  "SMMT",
  "TECX",
  "MLYS",
  "KYMR",
  "PHAT",
  "NMRA",
  "KROS",
  "ADGM",
  "ABOS",
  "NGNE",
  "SAGE",
  "ALEC",
  "ALDX",
  "AVTX",
  "AMLX",
  "JANX",
  "AVR",
  "BIOA",
  "PHGE",
  "BOLT",
  "CLRB",
  null,
  null,
  "CTNM",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "SYRE",
  "APGE",
  "ISRG",
  "ABUS",
  null,
  null,
  "KALA",
  "KRRO",
  "KALV",
  "LPTX",
  "LXEO",
  null,
  "MNPR",
  "NXTC",
  "OABI",
  "OVID",
  "OKUR",
  "RLYB",
  "PRQR",
  "QNCX",
  "PMVP",
  "RNXT",
  "SPRO",
  "SEPN",
  "STTK",
  "SGRY",
  "IOVA",
  null,
  null,
  null,
  null,
  "IKT",
  "TARA",
  "RZLT",
  "NVS",
  "TEVA",
  null,
  "ZYME",
  "ZURA",
  null,
  null,
  "OGN",
  "PFE",
  null,
  null,
  null,
  "REGN",
  null,
  null,
  "UPB",
  "RAPT",
  "PTGX",
  "PEPG",
  "AGIO",
  "AVXL",
  null,
  "SLDB",
  "TENX",
  "LYRA",
  "RYTM",
  "MLTX",
  "SLNO",
  "ACLX",
  null,
  "ETNB",
  "DYN",
  "ARDX",
  "CKPT",
  "SPRB",
  "TXMD",
  "GOSS",
  "SRPT",
  "NTRA",
  "WVE",
  "ROIV",
  null,
  null,
  "CNTB",
  "CNTX",
  "CDTX",
  "ELDN",
  "DCTH",
  null,
  "IMNM",
  "ITOS",
  "INZY",
  "KURA",
  "KZR",
  null,
  "VRNA",
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VRDN",
  "VYNE",
  "VYGR",
  "XENE",
  "XLO",
  "ZLAB",
  "XNCR",
  "ORKA",
  "BIIB",
  "BHVN",
  null,
  "IMVT",
  null,
  "PCVX",
  "BCRX",
  "BNTX",
  "BMRN",
  "BBIO",
  "CRGX",
  "CLDX",
  "CGON",
  "CLOV",
  "CRNX",
  "DAWN",
  "CTMX",
  "CYTK",
  "DNLI",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 198
Total Value: 523731625
Accession Number: 0001940272-25-000003
Form Type: 13F-HR
CIK: adar1-capital-management
Manager Name: Adar1-Capital-Management

Data Enrichment

82% identified

163 identified35 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

198 positions • $523,731.625K total value

198 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 4 of 10

Sort by:

KALA BIO, Inc.

KALA|483119202

Shares:299.0K

Value:$1.7M

Vir Biotechnology, Inc.

VIR|92764N102

Shares:250.0K

Value:$1.6M

ROCKET PHARMACEUTICALS, INC.

RCKT|77313F106

Shares:241.8K

Value:$1.6M

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:1.1M

Value:$1.5M

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:59.4K

Value:$1.4M

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:490.5K

Value:$1.4M

CARGO Therapeutics, Inc.

CRGX|14179K101

Shares:341.5K

Value:$1.4M

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:132.8K

Value:$1.4M

Verona Pharma plc

VRNA|925050106

Shares:20.0K

Value:$1.3M

Checkpoint Therapeutics, Inc.

CKPT|162828206

Shares:305.8K

Value:$1.2M

Aldeyra Therapeutics, Inc.

ALDX|01438T106

Shares:211.6K

Value:$1.2M

Korro Bio, Inc.

KRRO|500946108

Shares:68.7K

Value:$1.2M

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:168.8K

Value:$1.2M

Tectonic Therapeutic, Inc.

TECX|878972108

Shares:62.6K

Value:$1.1M

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:79.0K

Value:$1.1M

Vistagen Therapeutics, Inc.

VTGN|92840H400

Shares:420.8K

Value:$1.1M

PFIZER INC

PFE|717081103

Shares:41.0K

Value:$1.0M

G33033104

Shares:90.5K

Value:$1.0M

Surgery Partners, Inc.

SGRY|86881A100

Shares:40.0K

Value:$950.0K

Kiniksa Pharmaceuticals International, plc

KNSA|G52694109

Shares:41.4K

Value:$919.8K

Instrument	Shares		Other Manager	Value
KALA BIO, Inc.(KALAcusip483119202)	299.0K	QoQ +35.65% (+78.6K) YoY NEW(+299.0K)	All Managers (Combined)	$1.7M	QoQ +12.00% (+$183.6K) YoY NEW(+$1.7M)
Vir Biotechnology, Inc.(VIRcusip92764N102)	250.0K	QoQ +290.21% (+185.9K) YoY NEW(+250.0K)	All Managers (Combined)	$1.6M	QoQ +244.49% (+$1.1M) YoY NEW(+$1.6M)
ROCKET PHARMACEUTICALS, INC.(RCKTcusip77313F106)	241.8K	QoQ +14.38% (-30.4K) YoY NEW(+241.8K)	All Managers (Combined)	$1.6M	QoQ -39.30% (-$1.0M) YoY NEW(+$1.6M)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	1.1M	QoQ +500.03% (+888.6K) YoY +2351.28% (+1.0M)	All Managers (Combined)	$1.5M	QoQ +382.11% (+$1.2M) YoY +1087.20% (+$1.4M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	59.4K	QoQ +538.84% (+50.1K) YoY +312.56% (+45.0K)	All Managers (Combined)	$1.4M	QoQ +283.40% (+$1.1M) YoY +21.50% (+$253.9K)
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	490.5K	QoQ +149.95% (+294.3K) YoY +44.34% (-150.7K)	All Managers (Combined)	$1.4M	QoQ +53.16% (+$490.4K) YoY -55.96% (-$1.8M)
CARGO Therapeutics, Inc.(CRGXcusip14179K101)	341.5K	QoQ NEW(+341.5K) YoY NEW(+341.5K)	All Managers (Combined)	$1.4M	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	132.8K	QoQ NEW(+132.8K) YoY NEW(+132.8K)	All Managers (Combined)	$1.4M	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
Verona Pharma plc(VRNAcusip925050106)	20.0K	QoQ -31.27% (-9.1K) YoY NEW(+20.0K)	All Managers (Combined)	$1.3M	QoQ -6.03% (-$81.6K) YoY NEW(+$1.3M)
Checkpoint Therapeutics, Inc.(CKPTcusip162828206)	305.8K	QoQ NEW(+305.8K) YoY NEW(+305.8K)	All Managers (Combined)	$1.2M	QoQ NEW(+$1.2M) YoY NEW(+$1.2M)
Aldeyra Therapeutics, Inc.(ALDXcusip01438T106)	211.6K	QoQ -67.34% (-436.4K) YoY NEW(+211.6K)	All Managers (Combined)	$1.2M	QoQ -62.37% (-$2.0M) YoY NEW(+$1.2M)
Korro Bio, Inc.(KRROcusip500946108)	68.7K	QoQ +18.51% (-10.7K) YoY NEW(+68.7K)	All Managers (Combined)	$1.2M	QoQ -45.79% (-$1.0M) YoY NEW(+$1.2M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	168.8K	QoQ +105.22% (-86.5K) YoY NEW(+168.8K)	All Managers (Combined)	$1.2M	QoQ -2.22% (-$26.7K) YoY NEW(+$1.2M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	62.6K	QoQ +6.63% (-3.9K) YoY NEW(+62.6K)	All Managers (Combined)	$1.1M	QoQ -59.09% (-$1.6M) YoY NEW(+$1.1M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	79.0K	QoQ +203.84% (+53.0K) YoY +2998.03% (+76.5K)	All Managers (Combined)	$1.1M	QoQ +113.65% (+$566.5K) YoY +2285.03% (+$1.0M)
Vistagen Therapeutics, Inc.(VTGNcusip92840H400)	420.8K	QoQ +246.41% (+299.3K) YoY +367.83% (+330.8K)	All Managers (Combined)	$1.1M	QoQ +193.57% (+$693.6K) YoY +121.51% (+$577.0K)
PFIZER INC(PFEcusip717081103)	41.0K	QoQ +17.11% (+6.0K) YoY -61.39% (-65.3K)	All Managers (Combined)	$1.0M	QoQ +11.86% (+$110.3K) YoY -64.75% (-$1.9M)
(cusipG33033104)✕	90.5K	QoQ -34.90% (-48.5K) YoY NEW(+90.5K)	All Managers (Combined)	$1.0M	QoQ -33.89% (-$517.2K) YoY NEW(+$1.0M)
Surgery Partners, Inc.(SGRYcusip86881A100)	40.0K	QoQ NEW(+40.0K) YoY NEW(+40.0K)	All Managers (Combined)	$950.0K	QoQ NEW(+$950.0K) YoY NEW(+$950.0K)
Kiniksa Pharmaceuticals International, plc(KNSAcusipG52694109)	41.4K	QoQ -75.11% (-125.0K) YoY NEW(+41.4K)	All Managers (Combined)	$919.8K	QoQ -72.05% (-$2.4M) YoY NEW(+$919.8K)